UPDATE: Valeant Posts Q3 Net Loss

Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.

Valeant Pharmaceuticals International (NYSE: VRX) posted a loss in the third quarter.Valeant cut its full-year revenue forecast to a range of $5.7 billion to $5.9 billion, versus its earlier outlook of $5.8 billion to $6.2 billion. Valeant posted a quarterly loss of $973.2 million, or $2.92 per share, versus a year-ago profit of $7.6 million, or $0.02 per share. Excluding special items, its cash earnings climbed to $1.43 per share from $1.15 per share. Its revenue surged 74% to $1.54 billion. However, analysts were expecting earnings of $1.42 per share on revenue of $1.67 billion. Valeant shares fell 3.62% to $105.11 in pre-market trading.

Crypto Whales Are Loading Up — Are You?

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!